The FDA just approved dostarlimab-gxly (Jemperli) as the first immunotherapy for advanced rectal cancer in...
Pola-R-GemOx treatment significantly improves overall survival for relapsed/refractory DLBCL patients ineligible for stem cell transplant,...
Advanced practitioners enhance myeloma care by improving specialty access and helping patients manage bispecific antibody...
New treatment approved for lung cancer patients with ROS1-positive non–small cell lung cancer.
Abbott invests in advanced cancer testing to detect disease earlier and personalize treatments with innovative...
HistoSonics gains approval for its tissue treatment system to destroy tumors with sound waves, initially...